Novomix 30 30 Unit (Insulin Aspart SUSPENSION) 30 UNIT

NOVOMIX 30 30 Unit is a suspension of insulin aspart designed for subcutaneous administration. It is used to manage blood glucose levels in diabetes care. This medication is suitable for those requiring flexible insulin therapy.

Strength

30 UNIT

Pack Size

3ML

Manufacturer / TM Owner

NOVO NORDISK CANADA INC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

NOVOMIX 30 30 Unit is primarily used for the management of diabetes mellitus in adults and children. It works by helping the body to utilize glucose effectively, providing both rapid and prolonged insulin action. This makes it suitable for those needing flexible insulin therapy to control blood sugar levels throughout the day.

Side Effects

Common effects of NOVOMIX 30 30 Unit may include hypoglycemia, or low blood sugar, which can cause symptoms such as sweating, dizziness, and fatigue. Some users may also experience injection site reactions, including redness or itching. These effects vary among individuals and typically subside as the body adjusts to the medication.

Precautions & Warnings

NOVOMIX 30 30 Unit should be stored properly to maintain its effectiveness. It is important to follow the storage instructions provided, typically keeping it refrigerated and protecting it from light. Always check the expiration date before use. Consult a healthcare provider before starting any new medication.

Avoid Interactions

NOVOMIX 30 30 Unit may interact with other medications, including oral hypoglycemic agents, beta-blockers, and alcohol. These interactions can affect blood sugar levels and should be monitored closely. It is advisable to inform your healthcare provider about all medications you are taking to avoid potential interactions.

Frequently Asked Questions

NOVOMIX 30 30 Unit is used to manage blood glucose levels in individuals with diabetes mellitus, providing both rapid and prolonged insulin action.

NOVOMIX 30 30 Unit is administered subcutaneously, typically into the abdominal area, thigh, or upper arm. Follow the instructions provided by your healthcare provider.

Common side effects may include hypoglycemia, injection site reactions, and allergic reactions. These effects vary among individuals.

NOVOMIX 30 30 Unit may interact with other diabetes medications. Consult your healthcare provider before combining it with other treatments.

NOVOMIX 30 30 Unit should be stored in the refrigerator and protected from light. Always check the expiration date before use.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.